Immunovant to Present at the H.C. Wainwright Global Investment Conference on May 25th

Rhea-AI Summary

Immunovant (Nasdaq: IMVT) announced on May 23, 2022, that CEO Pete Salzmann will participate in a fireside chat at the H.C. Wainwright Global Investment Conference from May 23-26, 2022.

The chat is scheduled for May 25 at 12:30 pm ET and will be available via webcast on the company's Investor Relations page at www.immunovant.com.

Immunovant focuses on developing innovative therapies for autoimmune diseases, notably their investigational compound, batoclimab.

News Market Reaction – IMVT

+0.52%

1 alert

+0.52% News Effect

On the day this news was published, IMVT gained 0.52%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Global Investment Conference, taking place May 23^rd-26^th, 2022.

H.C. Wainwright Global Investment Conference fireside chat details:

Date:	Wednesday, May 25th, 2022
Time:	12:30 pm Eastern Time
Webcast:	The presentation will be available via webcast and can be accessed at the Investor Relations section of the Company’s website, located at www.immunovant.com.

About Immunovant, Inc. 

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As a leader in FcRn inhibitor technology, we are boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. Our investigational compound, batoclimab, is a novel, fully human, monoclonal antibody targeting the neonatal Fc receptor (FcRn). For additional information on the Company, please visit www.immunovant.com.

Contact:

Tom Dorney, MS, MBA
Director, Investor Relations & Strategy
Immunovant, Inc.
info@immunovant.com 

FAQ

When is the Immunovant fireside chat at the H.C. Wainwright Global Investment Conference?

The Immunovant fireside chat is scheduled for May 25, 2022, at 12:30 pm ET.

Where can I watch the Immunovant fireside chat?

The fireside chat will be available via webcast on Immunovant's Investor Relations section of their website.

What does Immunovant focus on?

Immunovant focuses on enabling normal lives for people with autoimmune diseases with innovative therapies.

What is batoclimab?

Batoclimab is Immunovant's investigational compound, a fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn).